Dublin, June 28, 2017 -- Research and Markets has announced the addition of the "Healthcare/Medical Simulation Market: Global Forecast to 2022" report to their offering.
Global Medical Simulation Market to Reach USD 2, 281.0 Million By 2022
Global medical simulation market is majorly driven by the growing need to curtail the healthcare costs which is primarily attributed to the shortage of healthcare professional, increased healthcare spending, increased administrative expenses, lifestyle choices, high end technologies, and growing incidences of chronic disorders and population in general. Growing preference to the minimal invasive surgeries and growing emphasize on the patient safety also has a positive impact on the growth of medical simulation market. Other than this, technological advancement and innovation in the recent times have covered the growth of medical simulation market. The high-end cost of medical simulators, unstable economies, limited availability of funds, and lack of humanitarian approach have negative impact on the growth of this market and could restrict it to some extent.
The research report on the medical simulation market provides comprehensive analysis of the global market with a country level analysis and helps in understanding the driving forces for the growth of this market. The report also provides analysis of major product, services and end users segments such as patient simulator, surgical simulator, endovascular simulator, ultrasound simulator, task trainers, simulation software, web based simulators, and simulation accessories.
The surgical simulator market is further sub-segmented laparoscopic surgical simulator, arthroscopic surgical simulator, cardiovascular surgical simulator, gynaecology surgical simulator. Similarly, the task trainer market is sub segmented as follows: basic life support trainers, respiratory & airway trainers, trauma care kits and trainers, paediatric& neonatal care trainers, obstetric trainers.
The simulation training services market is categorized into educational services, hospital services, and other vendor-based services. The major end-users of the medical simulation products and services are analysed by categorizing into academic institutes, hospitals, military, emergency medical services, and voluntary organizations.
The global medical simulation market is segmented by geography as North America, Europe, Asia-Pacific, and Rest of the World. These regions are further analysed at a country level with a detailed qualitative and quantitative analysis. North America is the major market in the global medical simulation market and is expected to dominate this market during the forecast period, with the U.S. contributing a major share, followed by Europe, and Asia-Pacific. On the other hand, the Asian market, especially India and China, is expected to witness a boost in demand for medical simulation products and services and are poised to register maximum growth over the next five-six years, as a result of their economic development, rising awareness of patient safety in these countries, huge patient base, and the growing focus of the global medical simulation players in these markets.
Market Dynamics
Drivers
- Rising Need To Curtail Mounting Healthcare Cost
- Medical Technology Revolution
- Growing Demand for Minimal Invasive Surgeries
- Revolution in Medical Education
- Growing Emphasis on Patient Safety and Outcomes
Restraints
- High End Cost of Simulators and Limited Availability of Funds
- Lack of Humanitarian Approach
Opportunities
- Shortage of Physicians Across the Developed Nations
- Untapped Market
Key Topics Covered:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Insights
5. Medical Simulation Market, By Product
6. Medical Simulation Market, By Services
7. Medical Simulation Market, By End User
8. Technological Assessment
9. Medical Simulation Market, By Geography
10. Competitive Landscape
11. Company Profiles
- 3-Dmed(Part Of 3-D Technical Services)
- 3b Scientific
- 3d Systems
- Adam, Rouilly
- Altay Scientific
- CAE Healthcare
- Cardionics
- Epona
- Gaumard Scientific
- Ingmar Medical
- Kavo Dental GmbH
- Kyoto Kagaku Co. Ltd.
- Laerdal Medical
- Limbs and Things
- Medical Simulation Corporation (Msc)
- Medishield B.V
- Mentice AB
- Simendo B.V.
- Simulab Corpoation
- Simulaids
- Surgical Science Sweden AB
- Tellyes Scientific Co., Ltd.
- Trucorp Ltd.
- Yuan Technology Limited
For more information about this report visit https://www.researchandmarkets.com/research/4pt4zm/healthcaremedical
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Healthcare Services, Surgical Devices , Virtual and Augmented Reality


American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Samsung Electronics Shares Jump on HBM4 Mass Production Report
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Anta Sports Expands Global Footprint With Strategic Puma Stake
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



